Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers.

Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.

Br J Cancer. 2014 Jan 7;110(1):164-71. doi: 10.1038/bjc.2013.698. Epub 2013 Nov 5.

2.

Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.

Alnabulsi A, Agouni A, Mitra S, Garcia-Murillas I, Carpenter B, Bird S, Murray GI.

J Pathol. 2012 Dec;228(4):471-81. doi: 10.1002/path.4031. Epub 2012 Aug 20.

PMID:
22450763
3.

High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells.

Fujikawa H, Tanaka K, Toiyama Y, Saigusa S, Inoue Y, Uchida K, Kusunoki M.

J Gastroenterol. 2012 Jul;47(7):775-84. doi: 10.1007/s00535-012-0532-0. Epub 2012 Feb 24.

PMID:
22361863
4.

microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.

Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, Wang H, Chen J, Ng SS, Chen M, Sung JJ, Yu J.

Oncogene. 2013 Oct 17;32(42):5078-88. doi: 10.1038/onc.2012.526. Epub 2012 Dec 3.

PMID:
23208495
5.

[Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].

Wang GH, Lu MH, Wang JC, Wang F, Ding WF, Wang YG, Ju SQ, Wang HM.

Zhonghua Zhong Liu Za Zhi. 2013 Apr;35(4):249-55. doi: 10.3760/cma.j.issn.0253-3766.2013.04.003. Chinese.

PMID:
23985251
6.

Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.

Wang L, Shi S, Guo Z, Zhang X, Han S, Yang A, Wen W, Zhu Q.

PLoS One. 2013 Jun 10;8(6):e65539. doi: 10.1371/journal.pone.0065539. Print 2013.

7.

GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.

Wang Z, Jiang B, Chen L, Di J, Cui M, Liu M, Ma Y, Yang H, Xing J, Zhang C, Yao Z, Zhang N, Dong B, Ji J, Su X.

J Transl Med. 2014 Jan 21;12:15. doi: 10.1186/1479-5876-12-15.

8.

Prognostic significance of TWEAK expression in colorectal cancer and effect of its inhibition on invasion.

Lin BR, Huang MT, Chen ST, Jeng YM, Li YJ, Liang JT, Lee PH, Chang KJ, Chang CC.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S385-94. doi: 10.1245/s10434-011-1825-x. Epub 2011 Jun 17.

PMID:
21681381
9.

Silencing of pancreatic adenocarcinoma upregulated factor by RNA interference inhibits the malignant phenotypes of human colorectal cancer cells.

Liu PF, Wu YY, Hu Y, Wang L, He SB, Zhu YB, Zhu XG.

Oncol Rep. 2013 Jul;30(1):213-20. doi: 10.3892/or.2013.2478. Epub 2013 May 15.

PMID:
23677445
10.

Effect of CLN3 silencing by RNA interference on the proliferation and apoptosis of human colorectal cancer cells.

Zhu X, Huang Z, Chen Y, Zhou J, Hu S, Zhi Q, Song S, Wang Y, Wan D, Gu W, Zhou H, Zhang B, Cao W, He S.

Biomed Pharmacother. 2014 Apr;68(3):253-8. doi: 10.1016/j.biopha.2013.12.010. Epub 2014 Jan 15.

PMID:
24556023
11.

Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.

Toiyama Y, Yasuda H, Saigusa S, Tanaka K, Inoue Y, Goel A, Kusunoki M.

Carcinogenesis. 2013 Nov;34(11):2548-57. doi: 10.1093/carcin/bgt282. Epub 2013 Sep 3.

12.

MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.

Nishida N, Yamashita S, Mimori K, Sudo T, Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y, Mori M.

Ann Surg Oncol. 2012 Sep;19(9):3065-71. doi: 10.1245/s10434-012-2246-1. Epub 2012 Feb 10.

PMID:
22322955
13.

Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.

Takahashi Y, Iwaya T, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.

Ann Surg Oncol. 2014 Jan;21(1):205-12. doi: 10.1245/s10434-013-3264-3. Epub 2013 Sep 18.

PMID:
24046120
14.

siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosis.

Kaneko N, Miura K, Gu Z, Karasawa H, Ohnuma S, Sasaki H, Tsukamoto N, Yokoyama S, Yamamura A, Nagase H, Shibata C, Sasaki I, Horii A.

Biochem Biophys Res Commun. 2009 Dec 25;390(4):1235-40. doi: 10.1016/j.bbrc.2009.10.127. Epub 2009 Oct 28.

PMID:
19878654
15.

The significance of PITX2 overexpression in human colorectal cancer.

Hirose H, Ishii H, Mimori K, Tanaka F, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Doki Y, Mori M.

Ann Surg Oncol. 2011 Oct;18(10):3005-12. doi: 10.1245/s10434-011-1653-z. Epub 2011 Apr 9.

PMID:
21479692
16.

Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells.

Ma K, Pan X, Fan P, He Y, Gu J, Wang W, Zhang T, Li Z, Luo X.

Mol Cancer. 2014 May 23;13:118. doi: 10.1186/1476-4598-13-118.

17.

Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.

Jao TM, Tsai MH, Lio HY, Weng WT, Chen CC, Tzeng ST, Chang CY, Lai YC, Yen SJ, Yu SL, Yang YC.

Int J Cancer. 2014 Dec 1;135(11):2593-603. doi: 10.1002/ijc.28899. Epub 2014 Apr 23.

18.

Expression of CLDN1 in colorectal cancer: a novel marker for prognosis.

Nakagawa S, Miyoshi N, Ishii H, Mimori K, Tanaka F, Sekimoto M, Doki Y, Mori M.

Int J Oncol. 2011 Oct;39(4):791-6. doi: 10.3892/ijo.2011.1102. Epub 2011 Jun 28.

PMID:
21720707
19.

Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.

Yamanashi T, Nakanishi Y, Fujii G, Akishima-Fukasawa Y, Moriya Y, Kanai Y, Watanabe M, Hirohashi S.

Oncology. 2009;77(1):53-62. doi: 10.1159/000226112. Epub 2009 Jun 25.

PMID:
19556810
20.

MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.

Ji D, Chen Z, Li M, Zhan T, Yao Y, Zhang Z, Xi J, Yan L, Gu J.

Mol Cancer. 2014 Apr 23;13:86. doi: 10.1186/1476-4598-13-86.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk